Meningioma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
|||
| Line 10: | Line 10: | ||
===Prevalence=== | ===Prevalence=== | ||
* The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref> | * The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref> | ||
* It was the most reported primary brain and central nervous system tumor in the Unites States between 2002 and 2006. It accounted for about 33.8% of the tumors reported, making it the most frequently diagnosed brain tumor.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=2945461 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref> | |||
* Meningioma is the second most common primary [[brain tumor]] worldwide.<ref name="pmid21955199">{{cite journal| author=Chamberlain MC, Barnholtz-Sloan JS| title=Medical treatment of recurrent meningiomas. | journal=Expert Rev Neurother | year= 2011 | volume= 11 | issue= 10 | pages= 1425-32 | pmid=21955199 | doi=10.1586/ern.11.38 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21955199 }} </ref> | * Meningioma is the second most common primary [[brain tumor]] worldwide.<ref name="pmid21955199">{{cite journal| author=Chamberlain MC, Barnholtz-Sloan JS| title=Medical treatment of recurrent meningiomas. | journal=Expert Rev Neurother | year= 2011 | volume= 11 | issue= 10 | pages= 1425-32 | pmid=21955199 | doi=10.1586/ern.11.38 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21955199 }} </ref> | ||
* Meningioma accounts for approximately 1 out of 3 primary [[brain]] and [[spinal cord]] [[tumor]]s.<ref name="C">Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25 2015</ref> | * Meningioma accounts for approximately 1 out of 3 primary [[brain]] and [[spinal cord]] [[tumor]]s.<ref name="C">Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25 2015</ref> | ||
Revision as of 19:38, 14 February 2019
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Meningioma epidemiology and demographics |
|
Risk calculators and risk factors for Meningioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.[1] The incidence of meningioma is approximately 7.62 per 100,000 individuals in the United States.[2] Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.[3] Females are more commonly affected with meningiomas than males.[1] Meningioma usually affects individuals of the African American race. Caucasian and Latin American individuals are less likely to develop meningioma.
Epidemiology and Demographics
Prevalence
- The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.[1]
- It was the most reported primary brain and central nervous system tumor in the Unites States between 2002 and 2006. It accounted for about 33.8% of the tumors reported, making it the most frequently diagnosed brain tumor.[1]
- Meningioma is the second most common primary brain tumor worldwide.[4]
- Meningioma accounts for approximately 1 out of 3 primary brain and spinal cord tumors.[5]
- The prevalence of meningioma was estimated to be around 170,000 individuals in the United States.[1]
- Benign meningiomas account for approximately 70% of all meningioma cases.[5]
- Atypical meningiomas account for approximately 15%–25% of all meningioma cases.
- Anaplastic or malignant meningiomas account for about 1%–3% of all meningioma cases.
Incidence
- The incidence of meningiomas is approximately 7.62 per 100,000 individuals in the United States.[2]
- The advent of modern sophisticated imaging studies tripled the incidence of asymptomatic meningiomas.[3]
Age
- Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.[3]
- Meningiomas are uncommon among patients before the age of 40 and should raise suspicion of neurofibromatosis type 2 (NF2) syndrome when found among young patients.[6]
Gender
- Females are more commonly affected with meningiomas than males.[1]
- The female to male ratio is approximately 2 to 1.
- The incidence of meningioma among females is approximately 10.22 per 100,000 individuals in the United States.[2]
- The incidence of meningioma among males is approximately 4.85 per 100,000 individuals in the United States.
- The female to male ratio of meningiomas may be inverted among affected patients who are younger than 15 years of age.[1]
Race
- Meningioma usually affects individuals of the African American race. Caucasian and Latin American individuals are less likely to develop meningioma.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Wiemels J, Wrensch M, Claus EB (2010). "Epidemiology and etiology of meningioma". J Neurooncol. 99 (3): 307–14. doi:10.1007/s11060-010-0386-3. PMC 2945461. PMID 20821343.
- ↑ 2.0 2.1 2.2 Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL (2015). "Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act". Cancer. 121 (14): 2400–10. doi:10.1002/cncr.29379. PMID 25872752.
- ↑ 3.0 3.1 3.2 Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015
- ↑ Chamberlain MC, Barnholtz-Sloan JS (2011). "Medical treatment of recurrent meningiomas". Expert Rev Neurother. 11 (10): 1425–32. doi:10.1586/ern.11.38. PMID 21955199.
- ↑ 5.0 5.1 Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25 2015
- ↑ Meningeoma. Radiopaedia(2015)http://radiopaedia.org/articles/meningioma Accessed on September, 25 2015